THE LATEST NEWS IN CANCER CLINICAL RESEARCH

MEDSIR joins the IGCS 2024 annual meeting: expanding horizons towards gynecologic oncology

MEDSIR takes part in the Nexus Conference to address the challenges and opportunities of geographic diversity in clinical trials

Highlights from ESMO 2024: The Next Frontier in Oncology

Brain metastases: an oncological challenge requiring innovative solutions and multidisciplinary approaches

MEDSIR presents new studies at ESMO that advance treatment of patients with poor prognosis cancers

Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

Highlights from the SNO/ASCO CNS Metastases Conference: unveiling new frontiers in cancer brain metastasis

Integration of Artificial Intelligence in Oncology Research

National Cancer Survivor Month

MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer

Highlights from ESMO BREAST 2024: Insights on locally advanced or metastatic HR-positive/HER2-negative breast cancer

MEDSIR, Debiopharm, initiate clinical collaboration to explore potential synergy of Debio 0123 & Sacituzumab Govitecan in advanced breast cancer

Bridging science to care: insights on translational studies and our presence at AACR Congress 2024

A Recap of the Think Tank Meeting in Breast Cancer in São Paulo, Brazil

MEDSIR Presents Two Translational Studies Focused on Biomarkers at AACR2024 Annual Meeting

The Lancet publishes positive results from the PHERGain study in patients with localized HER2-positive breast cancer

MEDSIR's Brainstorming Series: Pioneering Breakthroughs in Genitourinary Oncology

Biomarkers and cancer: the future in oncology is coming

World Rare Diseases Day: Bringing Awareness to the Uncommon

The Right to be Forgotten. What comes after the challenge of cancer?

MEDSIR's Brainstorming Series: Advancing Innovations in Thoracic Malignancies

Highlights from SABCS 2023: Presenting Five Studies to Wrap Up the Year

Press Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium

Press Release: PARSIFAL-LONG at San Antonio Breast Cancer Symposium